Search｜Photos & Images & Videos｜KYODO NEWS IMAGES INC

Premiere Le choix du pianiste - Paris AJ

Elisa Servier attends "Le choix du pianiste" Paris film premiere at Le Balzac cinema on January 28, 2025 in Paris, France. Photo by Alexis Jumeau/ABACAPRESS.COM

E

Premiere Le choix du pianiste - Paris AJ

Elisa Servier attends "Le choix du pianiste" Paris film premiere at Le Balzac cinema on January 28, 2025 in Paris, France. Photo by Alexis Jumeau/ABACAPRESS.COM

E

Premiere Le choix du pianiste - Paris AJ

Elisa Servier attends "Le choix du pianiste" Paris film premiere at Le Balzac cinema on January 28, 2025 in Paris, France. Photo by Alexis Jumeau/ABACAPRESS.COM

E

Gala de l’Enfance Majuscule - Paris

Elisa Servier and her daughter Manon attend the Gala de l’Enfance Majuscule at the salle Gaveau, on October 7, 2024 in Paris, France. Photo by David NIVIERE/ABACAPRESS.COM

E

Gala de l’Enfance Majuscule - Paris

Elisa Servier and her daughter Manon attend the Gala de l’Enfance Majuscule at the salle Gaveau, on October 7, 2024 in Paris, France. Photo by David NIVIERE/ABACAPRESS.COM

E

Gala de l’Enfance Majuscule - Paris

Elisa Servier and her daughter Manon attend the Gala de l’Enfance Majuscule at the salle Gaveau, on October 7, 2024 in Paris, France. Photo by David NIVIERE/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Sanofi To Sell Its Doliprane Production Subsidiary

Sanofi's Doliprane medecine boxes pictured in Camps-la-source, France on September 24, 2024. While Servier gave up on selling Biogaran at the beginning of September, the project to sell Opella, Sanofi’s healthcare subsidiary, which notably houses the iconic little yellow box, is still underway. Following the first indicative offers submitted in July, the takeover candidates had until 23 September to submit their firm takeover bids. Photo by Laurent Coust/ABACAPRESS.COM

E

Concerto For Peace By Omar Harfouch - Paris

Omar Harfouch, Elisa Servier attending a photocall for the Concerto For Peace by Omar Harfouch at the Theatre des Champs-Elysees on September 18, 2024 in Paris, France. Photo by Shootpix/ABACAPRESS.COM

E

Concerto For Peace By Omar Harfouch - Paris

Omar Harfouch, Elisa Servier attending a photocall for the Concerto For Peace by Omar Harfouch at the Theatre des Champs-Elysees on September 18, 2024 in Paris, France. Photo by Shootpix/ABACAPRESS.COM

E